Populations in the global health economy—from patients to physicians to scientists—are going mobile. These populations represent important flows and critical networks of demand, talent, and intellectual and financial resources. The global movement of scientists is an important source of change; their migration patterns create new hubs for health discovery. As a result, expect research to expand outside of traditional geographic centers in the United States and Europe to places like Singapore and Dubai.
Since 2005, a number of intellectual property (IP) and regulatory reforms have unlocked new opportunities for multinational companies (MNCs) in the Indian pharmaceutical market. However, the growth of the Indian pharmaceutical market is accompanied by uncertainty around the IP/regulatory environment, disease trends, prescription patterns, domestic research & development (R&D) capability, health care spending and enablers like health insurance and distribution infrastructure. In such a complex and uncertain environment, traditional strategic commitment must yield to strategic flexibility, which combines scenario planning with real options to not just manage uncertainty but exploit it for competitive advantage. Using strategic flexibility planning, a company contemplating entry or expansion in India could articulate the range of uncertainty the future might hold and may reduce the unknown to a manageable number of outcomes.
Key Trends
Movements that provide a richer understanding of what the future might hold
Mobile scientific populations create new hubs for health discovery:
- New migration patterns and flows of talent
Signals
Early indicators, innovations and examples that suggest larger trends
 | Mobile Sciences
The globalization of bioinformatics, innovation and production is moving technology-enabled research and delivery of care out of traditional settings. New R&D hubs are emerging in India, Brazil, Korea and Indonesia, while medical “centers of excellence” in the Gulf States, India and Singapore are affiliating with U.S. providers to support the growth of medical tourism. Additionally, shortages of scientists and health care workers in the U.S., Canada and Europe are prompting the insourcing of talent from India, Africa, the Caribbean and other regions. |
What is Industry Compass 2.0?
Produced by Deloitte LLP’s Health Sciences & Government Practice and Institute for the Future’s (IFTF) Health Horizons Program, the Industry Compass 2.0 is a visual guide designed to help you think about, plan for and navigate the future in an engaging and constructive way. The major elements of the Industry Compass 2.0 map – Drivers, Impact Zones, Trends, Signals, Hurdles, Landmarks and Artifacts – provide a framework for discussions about how the elements might interact and how your organization might respond to or even co-create the future.
Learn more about the issues, challenges and opportunities facing health care and life sciences stakeholders in the coming decade.
Related Research and Insights:
Perspective: Are People Really Your Most Important Asset?: A View from the Life Sciences Industry
Report: Medical Tourism: Consumers in Search of Value
Report: The Right Spice: Pharmaceutical Market Entry in India
Deloitte Review Article: Deep Talent, Vast Differences
Related Content:
Overview: Deloitte's Health Sciences Practice
As used in this document, ‘Deloitte’ means Deloitte LLP (and its subsidiaries). Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
